Steroid Non-responsive Hashimoto's Encephalopathy Improved by Rituximab
Journal of the Korean Neurological Association
;
: 19-21, 2018.
Artículo
en Coreano
| WPRIM
| ID: wpr-766632
ABSTRACT
Hashimoto's encephalopathy is a rare autoimmune disease, with symptoms of encephalopathy and high titers of serum anti-thyroid antibodies. Current diagnostic criteria include corticosteroid responsiveness, but in some cases, they are refractory to corticosteroids. In steroid non-responders, other immunomodulatory therapies could be applied. Recently, Rituximab is reported as a safe and effective treatment for Hashimoto's encephalopathy. We report a 50-year-old woman with Hashimoto's encephalopathy presented with confusion and catatonia who was refractory to corticosteroid and immunoglobulin but effectively treated with rituximab.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Enfermedades Autoinmunes
/
Hormonas Tiroideas
/
Encefalopatías
/
Inmunoglobulinas
/
Catatonia
/
Corticoesteroides
/
Inmunomodulación
/
Rituximab
/
Glucocorticoides
/
Anticuerpos
Límite:
Femenino
/
Humanos
Idioma:
Coreano
Revista:
Journal of the Korean Neurological Association
Año:
2018
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS